Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A Open access 29 August 2018 Pages: 451 - 456
Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use Katherine A. Lyseng-Williamson Adis Drug Q&A Open access 07 August 2018 Pages: 457 - 465
Consider using biological agents or stem cell therapy when managing perianal Crohn’s disease Adis Medical Writers Disease Management 21 August 2018 Pages: 466 - 471
If necessary, use antiarrhythmic drugs to treat acute and chronic supraventricular tachycardia in infants Adis Medical Writers Disease Management 07 June 2018 Pages: 472 - 476
First reports of adverse drug reactions Drug Reactions and Interactions 05 September 2018 Pages: 477 - 477
Characteristics of individuals who prefer branded innovator over generic medicines: a New Zealand general population survey Maria KleinstäuberKate MacKrillKeith J. Petrie Short Communication 10 August 2018 Pages: 478 - 483
Pethidine versus morphine in postoperative pain relief of opioid-dependent patients in Zagazig University Hospital, Asharqia, Egypt Dalia M. AminAhmed M. El Teliti Original Research Article 07 August 2018 Pages: 484 - 487
Adverse drug reactions to antiretroviral drugs and impact on treatment adherence among HIV patients in northwestern Nigeria Abubakar Musa IsaIbrahim Jatau AbubakarBasheer A. Z. Chedi Original Research Article 16 August 2018 Pages: 488 - 495
Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU Katherine A. Lyseng-WilliamsonJürgen Behr Correction 06 August 2018 Pages: 496 - 496